SS Innovations reports ~$22M preliminary 2024 revenue, almost 4x YoY; Q1 2025 est $6.4M

SS Innovations International, Inc.

2025-Q1 EPS reported -$0.03 revenue$5,120,610

Preliminary 2024 revenue ~$22M (unaudited), up from ~$5.5M in 2023; gross margin improved to 36.9% from 12.3%.
Q1 2025 estimated revenue ~$6.4M with ~45% gross margin; installations rose from 64 to 78 systems.
SSi Mantra systems installed at 75 hospitals; performed 3,500+ surgeries with zero device-related mortality.
Expects FDA & CE approvals by end of 2025/early 2026; also received CDSCO approval for telesurgery in India.
Appointed independent directors Tim Adams and Dr. Frederic Moll (founder of Intuitive Surgical) to board.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.